LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 9 of 15: Cell count and normalized growth rate inhibition values within biological replicate 2. - Dataset (ID:20246)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MDA-MB-231 | AZD 5438 | 3.33 | uM | LJP6 | 1 | J02 | 72 | hr | 1311 | 768 | 4870 | 0.1577 | -0.2464 |
MDA-MB-231 | AZD 5438 | 3.33 | uM | LJP6 | 2 | J02 | 72 | hr | 1311 | 736 | 4961 | 0.1483 | -0.2600 |
MDA-MB-231 | AZD 5438 | 3.33 | uM | LJP6 | 3 | J02 | 72 | hr | 1311 | 809 | 4973 | 0.1627 | -0.2222 |
MDA-MB-231 | AZD 5438 | 10 | uM | LJP6 | 1 | J01 | 72 | hr | 1311 | 679 | 4870 | 0.1394 | -0.2939 |
MDA-MB-231 | AZD 5438 | 10 | uM | LJP6 | 2 | J01 | 72 | hr | 1311 | 631 | 4961 | 0.1272 | -0.3170 |
MDA-MB-231 | AZD 5438 | 10 | uM | LJP6 | 3 | J01 | 72 | hr | 1311 | 647 | 4973 | 0.1301 | -0.3076 |
MDA-MB-231 | Pelitinib | 0.04 | uM | LJP5 | 1 | I18 | 72 | hr | 1311 | 5222 | 5128 | 1.0183 | 1.0185 |
MDA-MB-231 | Pelitinib | 0.04 | uM | LJP5 | 2 | I18 | 72 | hr | 1311 | 5359 | 5100 | 1.0508 | 1.0512 |
MDA-MB-231 | Pelitinib | 0.04 | uM | LJP5 | 3 | I18 | 72 | hr | 1311 | 5047 | 5010 | 1.0072 | 1.0074 |
MDA-MB-231 | Pelitinib | 0.12 | uM | LJP5 | 1 | I17 | 72 | hr | 1311 | 5282 | 5128 | 1.0300 | 1.0302 |
MDA-MB-231 | Pelitinib | 0.12 | uM | LJP5 | 2 | I17 | 72 | hr | 1311 | 5093 | 5100 | 0.9986 | 0.9986 |
MDA-MB-231 | Pelitinib | 0.12 | uM | LJP5 | 3 | I17 | 72 | hr | 1311 | 5386 | 5010 | 1.0749 | 1.0761 |
MDA-MB-231 | Pelitinib | 0.37 | uM | LJP5 | 1 | I16 | 72 | hr | 1311 | 4804 | 5128 | 0.9368 | 0.9347 |
MDA-MB-231 | Pelitinib | 0.37 | uM | LJP5 | 2 | I16 | 72 | hr | 1311 | 4552 | 5100 | 0.8926 | 0.8873 |
MDA-MB-231 | Pelitinib | 0.37 | uM | LJP5 | 3 | I16 | 72 | hr | 1311 | 4587 | 5010 | 0.9154 | 0.9106 |
MDA-MB-231 | Pelitinib | 1.11 | uM | LJP5 | 1 | I15 | 72 | hr | 1311 | 4480 | 5128 | 0.8736 | 0.8672 |
MDA-MB-231 | Pelitinib | 1.11 | uM | LJP5 | 2 | I15 | 72 | hr | 1311 | 4193 | 5100 | 0.8222 | 0.8098 |
MDA-MB-231 | Pelitinib | 1.11 | uM | LJP5 | 3 | I15 | 72 | hr | 1311 | 4319 | 5010 | 0.8619 | 0.8521 |
MDA-MB-231 | Pelitinib | 3.33 | uM | LJP5 | 1 | I14 | 72 | hr | 1311 | 3083 | 5128 | 0.6012 | 0.5441 |
MDA-MB-231 | Pelitinib | 3.33 | uM | LJP5 | 2 | I14 | 72 | hr | 1311 | 2622 | 5100 | 0.5141 | 0.4241 |
MDA-MB-231 | Pelitinib | 3.33 | uM | LJP5 | 3 | I14 | 72 | hr | 1311 | 2837 | 5010 | 0.5662 | 0.4903 |
MDA-MB-231 | Pelitinib | 10 | uM | LJP5 | 1 | I13 | 72 | hr | 1311 | 1088 | 5128 | 0.2122 | -0.0907 |
MDA-MB-231 | Pelitinib | 10 | uM | LJP5 | 2 | I13 | 72 | hr | 1311 | 957 | 5100 | 0.1877 | -0.1487 |
MDA-MB-231 | Pelitinib | 10 | uM | LJP5 | 3 | I13 | 72 | hr | 1311 | 1112 | 5010 | 0.2219 | -0.0819 |
MDA-MB-231 | Luminespib | 0.04 | uM | LJP5 | 1 | H18 | 72 | hr | 1311 | 972 | 5128 | 0.1895 | -0.1413 |